Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
SCPH

SCPH - Scpharmaceuticals Inc Stock Price, Fair Value and News

$5.67 
Market Closed

Price Targets

SCPH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SCPH Price Action

Last 7 days

0.4%

Last 30 days

2.7%

Last 90 days

42.8%

Trailing 12 Months

30.7%

SCPH RSI Chart

SCPH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SCPH Valuation

Market Cap

302.2M

Price/Earnings (Trailing)

-3.29

Price/Sales (Trailing)

6.05

Price/Free Cashflow

-4.59

SCPH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

SCPH Fundamentals

SCPH Revenue

Revenue (TTM)

50.0M

Rev. Growth (Yr)

99.17%

Rev. Growth (Qtr)

36.5%

SCPH Earnings

Earnings (TTM)

-91.7M

Earnings Growth (Yr)

-5.47%

Earnings Growth (Qtr)

8.7%

SCPH Profitability

Operating Margin

68.46%

Return on Equity

430.27%

Return on Assets

-114.28%

Free Cashflow Yield

-21.78%

SCPH Investor Care

Shares Dilution (1Y)

6.54%

Diluted EPS (TTM)

-1.79

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202542.0M50.0M00
202417.6M24.0M30.3M36.3M
202300013.6M
Get all data in R, Python etc through our Historical Stock Data APIs

About Scpharmaceuticals Inc

SCPH
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
 CEO
 WEBSITEscpharmaceuticals.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES96

Scpharmaceuticals Inc Frequently Asked Questions

SCPH is the stock ticker symbol of Scpharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Oct 08 2025, market cap of Scpharmaceuticals Inc is 302.2 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check SCPH's fair value in chart for subscribers.

The fair value guage provides a quick view whether SCPH is over valued or under valued. Whether Scpharmaceuticals Inc is cheap or expensive depends on the assumptions which impact Scpharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SCPH.

As of Wed Oct 08 2025, SCPH's PE ratio (Price to Earnings) is -3.29 and Price to Sales (PS) ratio is 6.05. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SCPH PE ratio will change depending on the future growth rate expectations of investors.